A CHESTER, ILLINOIS MAN WAS RECENTLY ARRESTED AND CHARGED FOR CRIMES AGAINST AT LEAST ONE MINOR. WHEN HIS MUGSHOT WAS SHARED, WITH THE CHARGES INCLUDED, SEVERAL OTHER YOUNG LADIES CAME FORWARD AND TOLD THEIR STORIES. (PHOTO).

Image
 A Chester, Illinois man was recently arrested and charged for crimes against  at least one minor. When his mugshot was shared, with the charges included, several other young ladies came forward and told their stories.  Joshua Addison, 37-years-old, was arrested and charged on September 25th for incidents that happened approximately May, 13th of this year. He is currently in the Randolph County Jail.  When the news broke, several (at least 6) females shared screenshots and stories alleging Addison had sent them inappropriate messages. One individual shared a screenshot exhibiting that she confronted Addison and reminded him they were cousins. In that same exchange, the young lady asked if Addison knew her age. The screenshot shows Addison stating that he hopes his "not blood" cousin was at least 18-years-old.  Two prior alleged targets of Addison have reached out to us. They urge you, if you have received inappropriate messages, or experienced inappropriate beha...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.